AP – A single daily pill that combines aspirin and four blood pressure and cholesterol medicines has passed its first big test, potentially offering a cheap, simple way to prevent both heart disease and stroke.
AP – The American Medical Association is seeking an investigation of claims that editors of its leading medical journal threatened a whistleblower who pointed out a researcher’s conflict of interest.
Reuters – Bundling three older blood-pressure medicines, a cholesterol-lowering drug and aspirin into a single pill shows promise as a way to reduce heart disease, new research showed on Monday.
AP – A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs.
Reuters – * Potential problems: breathing, blood sugar, temperature
Reuters – People with multiple sclerosis may have a lower risk of cancer, possibly because of lifestyle changes they make after they are diagnosed with the neurological condition, researchers said on Monday.
Reuters – Patients who got infusions of their own bone marrow stem cells after a heart attack experienced measurably better heart function, U.S. researchers reported on Monday.
HealthDay – SUNDAY, March 29 (HealthDay News) — A surgical procedure called
ventricular reconstruction that doctors hoped would improve symptoms in
people with heart failure does not seem to work, a new study has
found.
HealthDay – SUNDAY, March 29 (HealthDay News) — The hormone relaxin reduces
shortness of breath and cardiovascular death in people with heart failure
who also have high blood pressure, according to a phase 2 trial conducted
in eight countries.
Reuters – Safety advantages of Abbott Laboratories' Xience stent over Boston Scientific Corp's rival Taxus stent increased between two and three years, according to long-term data presented on Sunday.